Stay informed on the latest liposarcoma news. Subscribe to newsletter: bit.ly/SubscribeLip...
#Newsletter #Liposarcoma #LipoEducation

A new clinical trial is exploring SA53-OS, an MDM2 inhibitor, for people with advanced solid tumors, including #dedifferentiated #liposarcoma (#DDLPS). Learn more about this study, who may be eligible, and how the treatment is given.
clinicaltrials.gov/study/NCT065...
#ClinicalTrials #MDM2

Explore the Liposarcoma Support Network’s YouTube channel for #Liposarcoma stories, expert insights, and helpful resources. Check it out! bit.ly/YouTubeLSN
#Sarcoma #RareDisease #LipoCommunity

Sometimes progress isn't about finding a better treatment. It is about expanding options for patients who need them most. Sign the petition: brigimadlinpetition.org #SaveBrigimadlin #PatientVoices #Liposarcoma @boehringerglobal.bsky.social

The STC-15 (a METTL3 inhibitor) Phase 2 monotherapy trial is currently recruiting for #DDLPS patients. Learn more: clinicaltrials.gov/study/NCT069... #Liposarcoma #Sarcoma #RareCancer #METTL3Sinhibitor

New publication from experts examines the #BRIGHTLINE-1 trial and the potential of #brigimadlin for people with dedifferentiated #liposarcoma. Read more: bit.ly/BrigimadlinU... #DDLPS #SarcomaResearch #SaveBrigimadlin #PatientVoices @boehringerglobal.bsky.social

From reflections of Life Fest 2026, to clinical trial updates, and #PalliativeCare info - catch up on what’s happening in the lipo community. Read NL: bit.ly/LSN-SepNewsl... #Liposarcoma #Sarcoma #StrongerTogether